Home    eJManager.com Add Your Journal   |    Follow on Twitter   |    Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

IJAVMS. 2015; 9(5): 222-228


Efficacy of Indispron® D110 in the treatment of red mites (Dermanyssus gallinae) infestation in Specific Pathogens Free Poultry Flock in Vom, Nigeria

Goni Abraham Dogo, James Tanko, Rebecca Ari, Cecilia Kogi, Markus Biallah, Paul Davou Kaze, Samson James Shaibu, Hurbertus Kleeberg.

Abstract
The main objective of this study was to evaluate the efficacy of Indispron® D110 against the red mite (Dermanyssus gallinae) infestation in specific pathogen free birds reared for vaccine research and production in National Veterinary Research Institute (NVRI), Vom. A total 250 birds comprising of 150 harcowhite growers and 100 cockerels all at 16 weeks old were considered in this study. The Harcowhite were treated with Indispron® D110 according to manufacturer instructions for a period of 14 days while the cockerels were left as untreated control. The initial results showed a significant reduction of mites (85%) in mite’s population after three days of spraying in the first week. Thereafter, a drastic decline in the mite’s population as no clusters were seen in the environment and on the shanks three days after application on week two (2) indicative of 100% efficacious when compared with the control birds which still have clusters of red mites and scaly shanks. This is the first report on Indispron® D100 being used for treating red mites in Nigerian poultry farm and is therefore recommended for routine use in controlling ectoparasites in Poultry houses and to promote quality research in the country.

Key words: Keywords: Efficacy, Indispron® D110, Dermanyssus gallinae, specific pathogen free birds, Nigeria.



Share this Article




ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
Job Opportunities/Service Offers
eJManager OJMS
eJPort Journal Hosting
About ScopeMed
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of eJManager LLC Publishing for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons